Effects of Supplementing LCPUFA to the Diet of Pregnant Women: Data from RCT
Randomised controlled trials (RCTs) investigating the effect of n-3 long-chain polyunsaturated fatty acid (LCPUFA) supplementation on pregnancy outcomes were recently systematically reviewed for both low-risk (uncomplicated) and high-risk pregnancies. The duration of pregnancy was found to be significantly enhanced by n-3 LCPUFA supplementation in low-risk (two systematic reviews, weighted mean difference: 2.55 and 1.57 days, 95% CI: 1.13–4.07 and 0.35–2.78 days), but not in high-risk pregnancies. The relative risk of giving birth before the 34th week of gestation was found to be reduced by n-3 LCPUFA supplementation both in low-risk (0.69, 95% CI: 0.49–0.99) and in high-risk (0.39, 95% CI: 0.19–0.84) pregnancies. Recent evidence indicates that enhancement of maternal intake of n-3 LCPUFA prolongs the duration of gestation in low-risk pregnancies and may contribute to the prevention of early preterm birth in both low-risk and high-risk pregnancies.
KeywordsDocosahexaenoic acid long-chain polyunsaturated fatty acid pregnancy
Unable to display preview. Download preview PDF.
- Decsi, T. and B. Koletzko (2000) “Role of long-chain polyunsaturated fatty acids in early human neurodevelopment.” Nutr Neurosci 3:293–306.Google Scholar
- Dunstan, J.A., T.A. Mori, A. Barden, L.J. Beilin, A.L. Taylor, P.G. Holt, S.L. Prescott (2003) “Fish oil supplementation in pregnancy modifies neonatal allergen-specific immune responses and clinical outcomes in infants at high risk of atopy: a randomized, controlled trial.” J Allergy Clin Immunol 112:1178–1184.PubMedCrossRefGoogle Scholar
- Horvath, A., B. Koletzko, H. Szajewska (2007) “Effect of supplementation of women in high-risk pregnancies with long-chain polyunsaturated fatty acids on pregnancy outcomes and growth measures at birth: a meta-analysis of randomized controlled trials.” Brit J Nutr 10:1–7 (Epub ahead of print).Google Scholar
- Krauss-Etschmann, S., R. Shadid, C. Campoy, E. Hoster, H. Demmelmair, M. Jiménez, A. Gil, M. Rivero, B. Veszprémi, T. Decsi, B.V. Koletzko, Nutrition and Health Lifestyle (NUHEAL) Study Group (2007) “Effects of fish-oil and folate supplementation of pregnant women on maternal and fetal plasma concentrations of docosahexaenoic acid and eicosapentaenoic acid: a European randomized multicenter trial.” Am J Clin Nutr 85:1392–1400.PubMedGoogle Scholar
- Makrides, M., L. Duley, S.F. Olsen (2006) “Marine oil, and other prostaglandin precursor, supplementation for pregnancy uncomplicated by pre-eclampsia or intrauterine growth restriction.” Cochrane Database Syst Rev CD003402.Google Scholar
- Malcolm, C.A., D.L. McCulloch, C. Montgomery, A. Shepherd, L.T. Weaver (2003b) “Maternal docosahexaenoic acid supplementation during pregnancy and visual evoked potential development in term infants: a double blind, prospective, randomised trial.” Arch Dis Child Fetal Neonatal Ed 88:F383–F390.CrossRefGoogle Scholar
- Simmer, K (2001) “Longchain polyunsaturated fatty acid supplementation in infants born at term.” Cochrane Database Syst Rev CD000376.Google Scholar